Orange Health Labs hits ₹180 cr ARR pitching 60-min collection, 6-hr reports against Dr Lal, Metropolis
Backed by Accel and General Catalyst, Orange Health Labs is processing 300,000 samples a month in Bengaluru at 20% Ebitda margin, scaling a quick-commerce diagnostics model across Delhi, Hyderabad and Mumbai to challenge incumbents in India's fragmented $15-16 bn market by 2030.
Orange Health Labs is scaling on-demand diagnostics with 60-minute home collection and 6-hour reports, hitting ₹180 cr ARR across four metros, challenging Dr Lal, Metropolis, Tata 1mg and PharmEasy in India's fragmented $15-bn diagnostics market.
Why this matters
Orange Health Labs is scaling a quick-commerce diagnostics playbook into a category long dominated by Dr Lal PathLabs and Metropolis, signaling a shift toward speed-led service models in Indian healthcare retail.
Retail-company activity steady with 618 signals in the last 90 days.